<DOC>
	<DOCNO>NCT02101632</DOCNO>
	<brief_summary>Topical application BV ointment patient Research Diagnostic Criteria/Temporomandibular Disorder 1a 1b ( RDC/TMD ) experimental group , compare placebo ( vaseline ) control group.Application repeat 3 time day , 14 day . Surface electromyography ( EMG ) use measure masseter rest tonus maximal voluntary contraction tonus . Pain intensity also analyse VAS scale . Effectiveness BV compare placebo masseter myofascial pain patient TMD</brief_summary>
	<brief_title>Myorelaxant Effect Bee Venom ( BV ) Topical Skin Application Patients With RDC/TMD Ia Ib</brief_title>
	<detailed_description>The aim study evaluation myorelaxant action bee venom ( BV ) ointment , compare placebo.Parallel group , randomize double blind trial perform , include 79 patient painful RDC/TMD 1a 1b . Muscle tension measure twice ( TON1 TON2 ) rest muscle tonus ( RMT ) maximal muscle contraction ( MMC ) side right leave , Easy Train Myo EMG ( Version 3.1 ) . Pain intensity also analyse VAS scale</detailed_description>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>RDC/TMD 1a 1b agreement participate experimental study bee venom allergy hyperactivity bee product positive anamnesis anaphylactic reaction bee bite skin wound skin surface discontinuation RDC/TMD 2 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>TMD</keyword>
	<keyword>bee venom</keyword>
	<keyword>muscle tension</keyword>
	<keyword>muscle pain</keyword>
</DOC>